Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples